Nephrogenic systemic fibrosis: Summary of the special symposium

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 5, 2007, Pages 1179-1181

  Bongartz, Georg ^a,b   Kucharczyk, Walter ^c  

^a Radiology Department   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; GADODIAMIDE; GADOLINIUM PENTETATE; IRON;

CHELATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG STABILITY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HUMAN; HYDROPHOBICITY; LEGAL ASPECT; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL RESEARCH; NEPHROGENIC FIBROSING DERMOPATHY; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

EID: 35848955207     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21177     Document Type: Editorial

References (1)

1. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermatopathy? Nephrol Dial Transplant 2006 21:1104-1108.